Association of cytokine genetic polymorphism with hepatites B infection evolution in adult patients

Memorias do Instituto Oswaldo Cruz

Volumn 102, Issue 4, 2007, Pages 435-440

  Ribeiro, Cátia Silene Sversuti ^a   Visentainer, Jeane Eliete Laguila ^a   Moliterno, Ricardo Alberto ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Cytokine gene polymorphism; Genetic association; Hepatitis B

Indexed keywords

HEPATITIS B VIRUS;

EID: 34250893250     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762007005000043     Document Type: Article

References (40)

1. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV 1998. Genotypic variation in the transforming growth factor-1 gene. Transplantation 66: 1014-1020.
2. Ben-Ari Z, Mor E, Papo O, Kfir B, Sulkes J, Tambur AR, Tur-Kaspa R, Klein T 2003. Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol 98: 144-150.
3. Berlioz-Arthaud A, Perolat P, Buisson Y 2003. 10 year assessment of infant hepatitis B vaccination program, in the Loyalty Islands (New Caledonia). Vaccine 21: 2737-2742.
4. Bidwell JL, Wood NAP, Morse HR, Olomolaiye OO, Laundy GJ 1998. Human cytokine gene nucleotide sequence alignments. Eur J Immunogen 25: 83-265.
5. Bissel DM, Roulot D, George J 2001. Transforming growth factor β and liver. Hepatology 34: 859-867.
6. Chen Y, Wei H, Gao B, Hu Z, Zheng S, Tian Z 2005. Activation and function of hepatic NK cells in hepatitis B infection: an underinvestigated innate immune response. J Viral Hepatol 12: 38-45.
7. Cheong JY, Cho SW, Hwang IL, Yoon SK, Lee JH, Park CS, Lee JE, Hahm KB, Kim JH 2006. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-a gene promoter polymorphisms. J Gastroenterol Hepatol 21: 1163-1169.
8. Chu CJ, Lok ASF 2002. Clinical significance of hepatitis B virus genotypes. Hepatology 35: 922-929.
9. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson IV, Woo P 1999. Polymorphic haplotypes of the interleukin-10 5 flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthr Reumatol 42: 1101-1108.
10. Du T, Guo XH, Zhu XL, LI JH, Lu LP, Gao JR, Gou CY, Li Z, Liu Y, Li H 2006. Association of TNF-alpha promoter polymorphisms with the outcomes of hepatitis B virus infection in Chinese Han population. J Viral Hepatol 13: 618-624.
11. Ferrari C, Missale G, Boni C, Urbani S 2003. Immunopathogenesis of hepatitis B. J Hepatol 39: S36-S42.
12. Ferreira CT 2004. Hepatites virais: aspectos da epidemiologia e da prevenção. Rev Bras Epidemiol 7: 473-487.
13. Fishman D, Faulds G, Jeffry R, Mohamed-Alli V, Yudkin JS, Humphries S, Woo P 1998. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemiconset juvenile chronic arthritis. J Clin Invest 102: 1369-1376.
14. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV 1999. Viral clearance without destruction of infected cells during acute HBV infection. Science 284: 825-828.
15. Hajeer AH, Hutchinson IV 2001. Influence of TNF-a gene polymorphisms on TNF-a production and disease. Hum Immunol 62: 1191-1199.
16. Hodgson PD, Michalak TI 2001. Augmented hepatic interferon gamma expression and T-cell influx characterize acute hepatitis progressing to recovery and residual lifelong virus persistence in experimental adult woodchuck hepatitis virus infection. Hepatology 34: 1049-1058.
17. Hyodo N, Nakamura I, Imawari M 2004. Hepatitis B core antigen stimulates interleukin-10 secretion by both T cells and monocytes from peripheral blood of patients with chronic hepatitis B virus infection. Clin Exp Immunol 135: 462-466.
18. Jung MC, Pape GR 2002. Immunology of hepatitis B infection. Lancet Inf Dis 2: 43-50.
19. Kane M 1995. Global program for control of hepatitis B infection. Vaccine 13 (Suppl. 1): 47-49.
20. Kao JH, Chen PJ, Lai MY, Chen DS 2002. Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection. J Clin Microbool 40: 1207-1209.
21. Kim JH, Pyo CW, Hur SS, Kim YK, Kim TG 2003b. Influences of IL-1B, IL-1RN, TNF-α and TNF-β alleles on chronic HBV infection and perinatal infections of hepatitis B virus after immunoprophylaxis. Hum Immunol 64 (Suppl. 1): 5143.
22. Kim YJ, Lee HS, Yoon JH, Kim CY, Park MH, Kim LH, Park BL, Shin HD 2003a. Association of TNF-α promoter polymorphisms with clearance of hepatitis B virus infection. Hum Mol Gen 12: 2541-2546.
23. Kroeger KM, Carville KS, Abraham LJ 1997. The -308 tumor necrosis factor- ? promoter polymorphism effects transcription. Mol Immunol 34: 391-399.
24. Leifeld L, Cheng S, Ramakers J, Dumoulin FL, Trautwein C, Sauerbruch T, Spengler U 2002. Imbalanced intrahepatic expression of interleukin 12, interferon gamma, and interleukin 10 in fulminant hepatitis B. Hepatology 36: 1001-1008.
25. Letterio JJ, Roberts AB 1998. Regulation of immune response by TGF-β. Ann Rev Immunol 16: 137-161.
26. Lu LP, Li XW, Liu Y, Sun GC, Wang XP, Zhu XL, Hu QY, Li H 2004. Association of -238 G/A polymorphism of tumor necrosis factor-alpha gene promoter region with outcomes of hepatitis B virus infection in Chinese Han population. World J Gastroenterol 10: 1810-1814.
27. Ministério da Saúde 2003. Hepatites Virais. O Brasil Está Atento, Programa Nacional de Hepatites Virais, Brasília, p.1-20.
28. Miyazoe S, Hamasaki K, Nakata K, Kajiya Y, Kitajima K, Nakao K, Daikoku M, Yatsuhashi H, Koga M, Yano M, Eguchi K 2002. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am J Gastroenterol 97: 2086-2092.
29. Perrey C, Pravica V, Sinnott PJ, Hutchinson IV 1998. Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-β1 and tumor necrosis factor-α genes: a technical report. Transpl Immunol 6: 193-197.
30. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ., Hutchinson IV 1999. In vitro production of IFN-γ correlates with CA repeat polymorphism in the human IFN-γ gene. Eur J Immunogen 26: 1-3.
31. Probst CM, Bompeixe EP, Pereira NF, Dalalio MMO, Visentainer JEL, Tsuneto LT, Petzl-Erler ML 2000. HLA polymorphism and evaluation of European, African, and Amerindian contribution to the white and mulatto populations from Paraná, Brazil. Human Biol 72: 597-617.
32. Shih HH, Chang MH, Hsu HY, Lee PI, Ni YH, Chen DS 1999. Long term immune response of universal hepatitis B vaccination in infancy: a community-based study in Taiwan. Ped Inf Dis J 18: 427-432.
33. Suri D, Schilling R, Lopes AR, Mullerova I, Colucci G, Williams R, Naoumov NV 2001. Non-cytolitic inhibition of B virus replication in human hepatocytes. J Hepatol 35: 790-797.
34. Szkaradkiewicz A, Jopek A, Wysocki J, Grzymislawski M, Malecka I, Wozniak A 2003. HBcAg-specific cytokine production by CD4 T lymphocytes of children with acute and chronic hepatitis B. Virus Res 97: 127-133.
35. Thio CL, Carrington M, Marti D, O'Brien SJ, Vlahov D, Nelson KE, Astermborski J, Thomas DL 1999. Class II HLA alleles and hepatitis B virus persistence in African Americans. J Inf Dis 179: 1004-1006.
36. Thomas D, Strickland GT 2000. Viral Hepatitis. In TG Strickland, Hunter's Tropical Medicine and Emerging Infections Diseases, 8th ed., Saunders, Philadelphia, p. 231-235.
37. Thursz M 2001. Genetic susceptibility in chronic viral hepatitis. Ant Res 52: 113-116.
38. Visentainer JEL, Cavichioli AD, Sell AM, Lieber SR, Persoli LBL, Marques SBD, Vigorito AC, Aranha FJ, de Souza CA 2005. TNF-α, IL-6, IFN-γ, IL-10, and TGF-β1 genotypes among Brazilian caucasoids. Rev Bras Hematol Hemot 27 (Supl. 1): 61-65.
39. Xu XW, Lu MH, Tan DM 2005. Association between tumor necrosis factor gene polymorphisms and the clinical types of patients with chronic hepatitis B virus infection. Clin Microbiol Infect 11: 52-56.
40. Westendorp RGJ, Langermans JAM, Huizinga TWJ, Verweij CL, Sturk A 1997. Genetic influence on cytokine production in meningococcal disease. Lancet 349: 1912-1913.